Literature DB >> 25215129

Therapeutic benefits of mild hypothermia in patients successfully resuscitated from cardiac arrest: A meta-analysis.

Xiao-Ping Wang1, Qing-Ming Lin1, Shen Zhao1, Shi-Rong Lin1, Feng Chen1.   

Abstract

BACKGROUND: Good neurological outcome after cardiac arrest (CA) is hard to achieve for clinicians. Experimental and clinical evidence suggests that therapeutic mild hypothermia is beneficial. This study aimed to assess the effectiveness and safety of therapeutic mild hypothermia in patients successfully resuscitated from CA using a meta-analysis.
METHODS: We searched the MEDLINE (1966 to April 2012), OVID (1980 to April 2012), EMBASE (1980 to April 2012), Chinese bio-medical literature & retrieval system (CBM) (1978 to April 2012), Chinese medical current contents (CMCC) (1995 to April 2012), and Chinese medical academic conference (CMAC) (1994 to April 2012). Studies were included if 1) the study design was a randomized controlled trial (RCT); 2) the study population included patients successfully resuscitated from CA, and received either standard post-resuscitation care with normothermia or mild hypothermia; 3) the study provided data on good neurologic outcome and survival to hospital discharge. Relative risk (RR) and 95% confidence interval (CI) were used to pool the effect.
RESULTS: The study included four RCTs with a total of 417 patients successfully resuscitated from CA. Compared to standard post-resuscitation care with normothermia, patients in the hypothermia group were more likely to have good neurologic outcome (RR=1.43, 95% CI 1.14-1.80, P=0.002) and were more likely to survive to hospital discharge (RR=1.32, 95% CI 1.08-1.63, P=0.008). There was no significant difference in adverse events between the normothermia and hypothermia groups (P>0.05), nor heterogeneity and publication bias.
CONCLUSION: Therapeutic mild hypothermia improves neurologic outcome and survival in patients successfully resuscitated from CA.

Entities:  

Keywords:  Cardiac arrest; Cardiopulmonary resuscitation; Meta-analysis; Mild hypothermia; Return of spontaneous circulation

Year:  2013        PMID: 25215129      PMCID: PMC4129912          DOI: 10.5847/wjem.j.issn.1920-8642.2013.04.003

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  29 in total

1.  Mild Hypothermia Suppresses Calcium-Sensing Receptor (CaSR) Induction Following Forebrain Ischemia While Increasing GABA-B Receptor 1 (GABA-B-R1) Expression.

Authors:  Jong Youl Kim; Nuri Kim; Midori A Yenari; Wenhan Chang
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

2.  Mild hypothermia induced by a helmet device: a clinical feasibility study.

Authors:  S Hachimi-Idrissi; L Corne; G Ebinger; Y Michotte; L Huyghens
Journal:  Resuscitation       Date:  2001-12       Impact factor: 5.262

3.  [Clinicopathological analysis of sudden cardiac death cases by autopsy].

Authors:  Rong-chao Sun; Shu-dong Yang; Zhi-yi Zhou; Jia-bei Liang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2012-10-16

4.  Effect of mild hypothermia on ischemia-induced release of endothelin-1 in dog brain.

Authors:  A Takasu; K Yagi; Y Okada
Journal:  Resuscitation       Date:  1996-02       Impact factor: 5.262

5.  Treatment of traumatic brain injury with moderate hypothermia.

Authors:  D W Marion; L E Penrod; S F Kelsey; W D Obrist; P M Kochanek; A M Palmer; S R Wisniewski; S T DeKosky
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

6.  Infusion of 4°C normal saline can improve the neurological outcome in a porcine model of cardiac arrest.

Authors:  Shengqi Wang; Shuo Wang; Chunsheng Li
Journal:  J Trauma Acute Care Surg       Date:  2012-05       Impact factor: 3.313

7.  Prehospital therapeutic hypothermia for comatose survivors of cardiac arrest: a randomized controlled trial.

Authors:  A Kämäräinen; I Virkkunen; J Tenhunen; A Yli-Hankala; T Silfvast
Journal:  Acta Anaesthesiol Scand       Date:  2009-06-03       Impact factor: 2.105

8.  Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia.

Authors:  C Okuda; A Saito; M Miyazaki; K Kuriyama
Journal:  Pharmacol Biochem Behav       Date:  1986-01       Impact factor: 3.533

9.  [The protective effect of hypothermia in a new transient cerebral ischemic model of the rat--A 31P magnetic resonance spectroscopy in vivo study].

Authors:  A Mizuhara
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1996-01

10.  Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats.

Authors:  H Karibe; G J Zarow; S H Graham; P R Weinstein
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

View more
  3 in total

1.  Effects of mild hypothermia on the ROS and expression of caspase-3 mRNA and LC3 of hippocampus nerve cells in rats after cardiopulmonary resuscitation.

Authors:  Jian Lu; Yi Shen; Hui-Yin Qian; Li-Jun Liu; Bao-Chun Zhou; Yan Xiao; Jin-Ning Mao; Guo-Yin An; Ming-Zhong Rui; Tao Wang; Chang-Lai Zhu
Journal:  World J Emerg Med       Date:  2014

Review 2.  Mild therapeutic hypothermia in patients resuscitated from out-of-hospital cardiac arrest: A meta-analysis of randomized controlled trials.

Authors:  Pedro A Villablanca; Mohammed Makkiya; Evann Einsenberg; David F Briceno; Christia Panagiota; Mark Menegus; Mario Garcia; Daniel Sims; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2016 Jan-Mar

Review 3.  Targeted temperature management in the ICU: guidelines from a French expert panel.

Authors:  Alain Cariou; Jean-François Payen; Karim Asehnoune; Gerard Audibert; Astrid Botte; Olivier Brissaud; Guillaume Debaty; Sandrine Deltour; Nicolas Deye; Nicolas Engrand; Gilles Francony; Stéphane Legriel; Bruno Levy; Philippe Meyer; Jean-Christophe Orban; Sylvain Renolleau; Bernard Vigue; Laure De Saint Blanquat; Cyrille Mathien; Lionel Velly
Journal:  Ann Intensive Care       Date:  2017-06-19       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.